PCV26 - Estimating The Incremental Resource Utilization And Economic Cost Attributable To Heart Failure In South Korea

Abstract

Owing to the increasing age of the Korean population, the prevalence of heart failure (HF) and its economic burden are also increasing. This study aimed to assess the economic impact of HF from the restricted societal perspective. A prevalence-based, incremental cost-of-patient study was performed to estimate the incremental resource use and costs for all-causes among adult HF patients compared to those without HF. We defined adult HF patients as those aged ≥19 years who had at least one insurance claim record with a primary or a secondary diagnosis of HF (ICD-10 codes of I11.0, I13.0, I13.2, I50.x) from the 2014 Health Insurance Review and Assessment Service-National Patients Sample (HIRA-NPS) claims data. The average annual per-capita cost was estimated to be $6,978, $2,097, and $4,176 for HF patients (n=14,252 patients), non-matched controls (n=1,116,882), and age- and gender-matched controls (n=57,008), respectively. The incremental cost per case of HF compared to that of matched controls was $2,802, which is about 1.70 times higher. In the multiple regression model, the mean expenditure was 1.4-fold higher for patients with HF than for matched controls. Simple conclusions as to whether the estimated economic burden of HF is large or small are not easy to make. However, the strong correlation between aging and the incidence of HF validates that the prevalence of this chronic condition will continue to increase, resulting in an enduring societal burden. Thus, greater emphasis on the prevention and treatment of HF is.